Background- Each year approximately 15 million people around the world are affected by stroke, about six million die, while five million suffer from severe disabilities. Oropharyngeal dysphagia (OD) is a frequent comorbidity, affecting between 37% and 78% of stroke patients. The early assessment of dysphagia has a significant influence on the patient’s health, on hospitalization times and ultimately on the costs of care for the stroke patient. Nonetheless, there is a gap between recommendations and clinical reality. The objective of this study is the validation of a screening tool, Dysphagia Risk Score 2 (DRS2), consisting of 8 items, whose administration takes about 120 seconds. Methods- The study involved 1006 patients (499 female and 507 male), aged between 15 and 101 years (mean age 70), evaluated with the DRS2 within 24/48 hours of admission to the Stroke Unit of the A.O. San Camillo-Forlanini in Rome and the San Giovanni Battista Hospital. Patients were enrolled in order of admission. To validate the scale, out of those 1006 patients, a random sample of 168 subjects (100 male and 68 female, mean age 71) also underwent an examination with a fiberoptic endoscopic evaluation of swallowing (FEES) during the same diagnostic session. To evaluate the reproducibility of the DRS2 score, a random sample of 35 of the total 1006 patients was evaluated simultaneously by an experienced observer and two inexperienced ones by blinded administration of DRS2. Results -The bivariate correlation between risk classification and risk index calculated as a parametric correlation r of Pearson (Pearson’s Correlation Coefficient), and nonparametric correlation Spearman rho (Rank Correlation Coefficient) highlights a significance of r = 0.777 p = 0.01: ρ = 0.790 p = 0.01. The analysis of the Roc curve shows the levels of sensitivity and specificity with an area under the curve of 0.90 and a p value = 0.001, with a confidence interval (CI) between 0.822 and 0.952. The concordance of the two scales, the screening test and the endoscopic evaluation of swallowing, is equal to 0.93 or 93% (with P-value = 0.0001). The data analysis on the inter-observer reproducibility of the DRS2 score shows the agreement is perfect as the Cohen’s Kappa value is between 0.81 and 1.00. Conclusion - Statistical analysis demonstrated the validity of DRS2, which proved to be a reliable and sensitive tool for detecting the risk of dysphagia in a population of patients suffering from acute stroke. DRS2 assessments are reproducible, also in case of administration by operators without a specific experience, if they undergo a specific training. The tool has also been well accepted by operators for its simplicity and execution rate.
Dysphagia Risk Score two (DRS2): Development and validation of a rapid screening card for dysphagia in patients with stroke
Abstract
Keywords
Download
Amitrano A., Rossi G., Acquaviva G., Fabbri S., Anticoli S., Burani N., Felzani G., Galeoto G., Ruoppolo G., Pezzella F. R. (2023) "Dysphagia Risk Score two (DRS2): Development and validation of a rapid screening card for dysphagia in patients with stroke
" Audiologia e Foniatria, 8(1), 34-42. DOI: 10.14658/pupj-IJAP-2023-1-5
Year of Publication
2023
Journal
Audiologia e Foniatria
Volume
8
Issue Number
1
Start Page
34
Last Page
42
Date Published
11/2023
ISSN Number
2531-7008
Serial Article Number
5
DOI
10.14658/pupj-IJAP-2023-1-5
Section
Articles